Quarterly Results

ZORA PHARMA LTD.

NSE : NABSE : 524438ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2007
Sep 2007
Jun 2007
Mar 2007
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
0.05
0.11
0.19
0.04
Total Expenditure
0.99
0.81
0.61
0.67
PBIDT (Excl OI)
-0.94
-0.7
-0.42
-0.63
Other Income
0.00
NA
0.00
0.00
Operating Profit
-0.94
-0.7
-0.42
-0.63
Interest
0.01
0.00
NA
0.00
Exceptional Items
NA
NA
NA
NA
PBDT
-0.95
-0.7
-0.42
-0.63
Depreciation
1.2
1.2
1.2
1.2
Profit Before Tax
-2.15
-1.9
-1.62
-1.83
Tax
0.01
0.01
0.01
0.00
Provisions and contingencies
0.00
NA
0.00
0.00
Profit After Tax
-2.16
-1.91
-1.63
-1.83
Extraordinary Items
NA
NA
0.00
0.00
Prior Period Expenses
100
NA
0.00
0.00
Other Adjustments
NA
NA
NA
NA
Net Profit
97.84
-1.91
-1.63
-1.83
Equity Capital
62.43
62.43
62.43
62.43
Face Value (IN RS)
10
10
10
10
Reserves
0
0
0
Calculated EPS
-0.34
-0.30
-0.26
-0.29
Calculated EPS (Annualised)
-1.38
-1.22
-1.04
-1.17
No of Public Share Holdings
NA
NA
NA
NA
% of Public Share Holdings
NA
NA
NA
NA
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-1880
-636.36
-221.05
-1575
PBIDTM%
-1880
-636.36
-221.05
-1575
PBDTM%
-1900
-636.36
-221.05
-1575
PBTM%
-4300
-1727.27
-852.63
-4575
PATM%
-4320
-1736.36
-857.89
-4575
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.